BARD1 Life Sciences Limited [ASX:BD1] share price and news 2022

Company Description

BARD1 Life Sciences Limited (BD1, formerly Eurogold Limited) diagnostics company with a portfolio of diagnostic technologies and products. The Company is focused on developing and commercialising best-in-class lifesaving diagnostic solutions for healthcare professionals and patients. The company’s programs are focussed on the development and commercialisation of diagnostic tests for early detection of cancer including ovarian, breast, lung, prostate, bladder and pancreatic cancers.

BARD1 Life Sciences Limited belongs to Health Care sector and under industry of Health Care Services. You can get more information about this company via their website: http://www.bard1.com.

This a small cap company with market cap of 318 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 28.1 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how bd1 dividend grows in the recent years.

No data